(Press-News.org) AUSTIN, Minn. (4/30/15) - Taking aspirin reduces a person's risk of colorectal cancer, but the molecular mechanisms involved have remained unknown until a recent discovery by The Hormel Institute, University of Minnesota.
Researchers led by The Hormel Institute's Executive Director Dr. Zigang Dong and Associate Director Dr. Ann M. Bode, who co-lead the Cellular & Molecular Biology section, discovered that aspirin might exert its chemopreventive activity against colorectal cancer, at least partially, by normalizing the expression of epidermal growth factor receptor (EGFR) in gastrointestinal precancerous lesions. EGFR is overexpressed in about 80 percent of cases involving colorectal cancer, the third-leading cause of cancer-related death in the United States.
Recently published in the open-access journal EBioMedicine, the Hormel Institute's study revealed a previously unknown functional association between EGFR and COX-2 - an enzyme associated with pain and inflammation - during the development of colorectal cancer. The study also provides an explanation as to how taking aspirin can lower the risk of colorectal cancer in patients with familial adenomatous polyposis (FAP), a rare, inherited condition that causes extra tissue, or polyps, to form in the large intestine. Polyps left untreated almost always become cancerous by age 40.
For this study, The Hormel Institute partnered with Mayo Clinic researchers who provided tissue sections from recruited FAP patients who were classified as regular aspirin users or nonusers. Consistent clinical trial data strongly suggests that regular use of aspirin and other non-steroidal, anti-inflammatory drugs lowers a person's lifetime risk of developing colorectal cancer.
Institute researchers found that COX-2 might drive the formation of tumors, at least in part, through the upregulation of EGFR. Given that, researchers believe EGFR might be a novel target for preventing colorectal cancer.
"We found that EGFR overexpression is an early event in the formation of colorectal cancer that can be greatly reduced by regular use of aspirin," Dr. Zigang Dong said. "Our findings are highly interesting, but more research is needed."
A short commentary also published on EBioMedicine by Dr. Paola Patrignani of Italy's "G. d'Annunzio" University of Chieti, highlighting The Hormel Institute's latest paper while discussing the potential use of aspirin for cancer prevention.
"The accumulating data from randomized clinical trials provide the rationale to consider the potential role of daily aspirin use in colorectal cancer prevention and possibly other types of cancer," Patrignani wrote in her commentary titled "COX-2 and EGFR: partners in crime split by aspirin."
Some questions, however, need to be addressed, Patrignani wrote, before recommending the prophylactic use of aspirin for cancer prevention, such as whether the chemopreventive effect is dose-dependent and whether daily, low-dose aspirin affect other types of cancers in addition to colorectal cancer. Clinical studies should be performed, she added, to verify whether the coadministration of low-dose aspirin and possibly other antiplatelet agents may lead to overcoming the resistance to EGFR inhibitors in cancer treatment.
This latest research follows another paper published last December in EBioMedicine by The Hormel Institute's Dong/Bode team related to colorectal cancer that provided a promising strategy for preventing and treating the disease. That study showed evidence that the TXA2 pathway also plays an important role in the processes leading to colorectal cancer, and laid the groundwork for introducing a strategy to target TXA2 for colorectal cancer prevention, early detection and management.
While reliable biomarkers remain a serious issue for the early detection of colorectal cancer, The Hormel Institute's findings in that study suggest that circulating TXA2 levels might have a potential prognostic or predictive value for detecting colorectal cancer early. Work is underway to further confirm the biomarker's clinical performance.
This month, Dr. Zigang Dong also received a grant for more than $1.7 million over five years from the National Cancer Institute to continue his team's supercomputer-assisted development of agents that are more effective and less toxic in preventing and treating colorectal cancer.
Through the use of The Hormel Institute's two IBM supercomputers, Drs. Dong and Bode have discovered three small molecules highly effective at suppressing colon cancer cell growth by inhibiting β-catenin, an enzyme strongly expressed in many cancer cell types that promotes growth and tumor formation.
INFORMATION:
The Hormel Institute's new EBioScience paper: http://www.sciencedirect.com/science/article/pii/S2352396415000869
Dr. Paola Patrignan's short commentary: http://www.sciencedirect.com/science/article/pii/S2352396415001073
The Hormel Institute, University of Minnesota
Started in 1942 by Jay C. Hormel, The Hormel Institute, University of Minnesota is comprised of a group of highly successful medical scientists who are focused on determining the basic molecular mechanisms of cancer development to develop new anti-cancer agents. In summer 2014, The Hormel Institute started a major expansion to double in size, adding 20 state-of-the-art laboratories and better space for its International Center of Research Technology. The project is expected to be completed in early 2016 along with a new Live Learning Center that will include a 250-seat auditorium and advanced technology to facilitate international medical research collaborations and presentations. Overall, The Hormel Institute's new expansion is expected to add about 120 faculty and staff jobs in the coming years, growing the Institute to about 250 overall.
New York, NY (April 30, 2015) - The use of integrative medicine interventions leads to significant improvements in patient activation and patient-reported outcomes in the treatment of chronic pain, depression, and stress, according to a new report released by The Bravewell Collaborative. The findings are based on data collected by the Patients Receiving Integrative Medicine Interventions Effectiveness Registry (PRIMIER), the first-ever patient registry on integrative medicine.
"We are encouraged by these early results, and we see tremendous potential for PRIMIER to provide ...
Philadelphia, April 30, 2015 -- The American College of Physicians (ACP) today released clinical advice aimed at reducing overuse of cervical cancer screening in average risk women without symptoms. "Cervical Cancer Screening in Average Risk Women" is published in Annals of Internal Medicine and lists two concurring organizations: the American Congress of Obstetricians and Gynecologists and the American Society for Clinical Pathology.
"ACP's advice for cervical cancer screening is designed to maximize the benefits and minimize the harms of testing," said Dr. David Fleming, ...
1. American College of Physicians releases Best Practice Advice for the proper time, test, and interval for cervical cancer screening
ACP's advice is supported by ACOG and endorsed by ASCP
New clinical advice from the American College of Physicians (ACP) aims to reduce overuse of cervical cancer screening in average risk women without symptoms. "Cervical Cancer Screening in Average Risk Women" is published in Annals of Internal Medicine and lists two concurring organizations: the American Congress of Obstetricians and Gynecologists and the American Society for Clinical ...
HOUSTON - (April 30, 2015) - The percentage of Texans without health insurance dropped 31 percent since enrollment began in the Affordable Care Act's (ACA) Health Insurance Marketplace, according to a new report released today by the Episcopal Health Foundation and Rice University's Baker Institute for Public Policy.
The report found that from September 2013 to March 2015, the percentage of uninsured adult Texans ages 18-64 dropped from 25 to 17 percent.
"This is a dramatic drop that's unprecedented in Texas," said Elena Marks, president and CEO of the Episcopal Health ...
Due to a lack of suitable studies, no conclusions can be drawn on the patient-relevant benefit or harm of screening for asymptomatic bacteriuria (ASB) in pregnant women. The benefit of antibiotic treatment of ASB following screening is also an open issue, as the results of the over 40-year-old studies cannot be applied to the current healthcare situation. This is the result of the final report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 23 April 2015, which was commissioned by the Federal Joint Committee (G-BA).
Maternity guidelines ...
A team of scientists has shed light on the dynamics of the creation, collaboration and dissemination processes involved in classical music works and styles. Their study focuses on analysing networks of composers contemporary to CD publications, using modern data analysis and data modelling techniques. These findings have just been published in EPJ Data Science by Doheum Park from the Graduate School of Culture Technology at Korea Advanced Institute of Science and Technology in Daejeon and colleagues. This work explores the nature of culture in novel ways, as part of a broader ...
This news release is available in French. Quebec City, April 30, 2015--Noroviruses, a group of viruses responsible for over 50% of global gastroenteritis cases, can spread by air up to several meters from an infected person according to a new study by Université Laval researchers. The discovery, details of which are presented in the latest issue of Clinical Infectious Diseases, suggests that measures applied in hospitals during gastroenteritis outbreaks may be insufficient to effectively contain this kind of infection.
The team led by Caroline Duchaine, professor ...
TAMPA, Fla. - DNA can be damaged by different environmental insults, such as ultraviolet light, ionizing radiation, oxidative stress or certain drugs. If the DNA is not repaired, cells may begin growing uncontrollably, leading to the development of cancer. Therefore, cells must maintain an intricate regulatory network to ensure that their DNA remains intact. Moffitt Cancer Center researchers have discovered a novel mechanism that controls a cell's response to DNA damage.
The protein SIRT1 plays an important role in controlling DNA damage. It can sense the presence of ...
Few doctors are prescribing a low-cost drug that has been proven effective in preventing the onset of diabetes, according to a UCLA study. The study, published in the peer-reviewed journal Annals of Internal Medicine, found that only 3.7 percent of U.S. adults with pre-diabetes were prescribed metformin during a recent three-year period.
Metformin and lifestyle changes both can prevent the onset of diabetes, but people often struggle to adopt healthier habits, according to Dr. Tannaz Moin, the study's lead author and an assistant professor of medicine in the division ...
The international Solar Wind Sherpas team, led by Dr. Shadia Habbal of the University of Hawaii at Manoa Institute for Astronomy, braved Arctic weather to successfully observe the total solar eclipse of March 20 from Longyearbyen on the island of Spitsbergen in the Svalbard archipelago east of northern Greenland. Their preliminary results are being presented Thursday at the Triennial Earth-Sun Summit in Indianapolis, IN.
It was no easy feat. Ever-changing weather predictions, subfreezing temperatures of -4 degrees F (-20 C) and the danger from polar bears were some of ...
